Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-23 Sale | 2023-01-24 5:11 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $22 | $274,988 | 1,744,634 (Indirect Direct) | View |
| 2023-01-20 Sale | 2023-01-23 6:00 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $22.75 | $227,523 | 268,810 (Direct) | View |
| 2023-01-10 Sale | 2023-01-11 5:09 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $22.86 | $228,644 | 2,250,148 (Indirect Direct) | View |
| 2023-01-03 Sale | 2023-01-04 5:51 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 25,000 | $20.65 | $516,147 | 2,930,761 (Indirect) | View |
| 2022-12-21 Sale | 2022-12-22 5:50 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20.32 | $253,969 | 1,755,572 (Indirect Direct) | View |
| 2022-12-20 Sale | 2022-12-22 5:43 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $20.07 | $200,650 | 276,497 (Direct) | View |
| 2022-12-08 Sale | 2022-12-12 4:56 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 4,358 | $22.08 | $96,210 | 2,955,761 (Indirect) | View |
| 2022-12-01 Sale | 2022-12-05 4:57 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 10,000 | $21.65 | $216,480 | 2,960,119 (Indirect) | View |
| 2022-12-01 Sale | 2022-12-05 4:43 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $21.45 | $214,530 | 2,260,148 (Indirect Direct) | View |
| 2022-11-21 Sale | 2022-11-22 6:46 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $20.76 | $207,570 | 286,497 (Direct) | View |
| 2022-11-21 Sale | 2022-11-22 6:43 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20.76 | $259,479 | 1,768,072 (Indirect Direct) | View |
| 2022-11-15 Sale | 2022-11-17 5:49 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 430 | $21.46 | $9,228 | 312,997 (Direct) | View |
| 2022-11-15 Sale | 2022-11-17 5:41 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 377 | $21.46 | $8,090 | 2,284,400 (Indirect Direct) | View |
| 2022-11-15 Sale | 2022-11-17 5:33 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 1,513 | $21.46 | $32,469 | 1,823,324 (Indirect Direct) | View |
| 2022-11-01 Sale | 2022-11-03 5:49 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $20.03 | $200,313 | 294,401 (Direct) | View |
| 2022-11-01 Sale | 2022-11-03 5:44 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 10,000 | $20.03 | $200,278 | 2,970,119 (Indirect) | View |
| 2022-11-01 Sale | 2022-11-03 5:36 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $20 | $200,050 | 2,269,338 (Indirect Direct) | View |
| 2022-11-01 Sale | 2022-11-03 5:30 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20.03 | $250,355 | 1,778,523 (Indirect Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $20.05 | $200,473 | 304,401 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:32 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 10,000 | $20.03 | $200,315 | 7,394,527 (Indirect) | View |
| 2022-10-03 Sale | 2022-10-05 4:25 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $19.99 | $199,852 | 2,279,338 (Indirect Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:22 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20.05 | $250,646 | 1,791,023 (Indirect Direct) | View |
| 2022-09-21 Sale | 2022-09-22 4:00 pm | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 613,603 | $18.55 | $11,380,779 | 8,464,301 (Direct) | View |
| 2022-09-21 Sale | 2022-09-22 4:00 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 613,603 | $18.55 | $11,380,779 | 8,904,527 (Indirect) | View |
| 2022-09-16 Sale | 2022-09-20 6:05 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 340,702 | $20.44 | $6,963,116 | 9,517,624 (Indirect) | View |
| 2022-09-16 Sale | 2022-09-20 5:47 pm | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 340,702 | $20.44 | $6,963,116 | 9,077,904 (Direct) | View |
| 2022-09-13 Sale | 2022-09-15 7:53 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 245,039 | $23.76 | $5,823,084 | 9,858,326 (Indirect) | View |
| 2022-09-13 Sale | 2022-09-15 7:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 245,039 | $23.76 | $5,823,084 | 9,418,606 (Direct) | View |
| 2022-09-02 Sale | 2022-09-15 1:21 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 5,000 | $23.82 | $119,108 | 10,103,365 (Indirect) | View |
| 2022-09-01 Sale | 2022-09-06 7:54 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 10,000 | $23.25 | $232,484 | 314,401 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:52 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 5,000 | $23.27 | $116,358 | 10,108,365 (Indirect) | View |
| 2022-09-01 Sale | 2022-09-06 7:51 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $23.25 | $232,452 | 2,289,338 (Indirect Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:50 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $23.25 | $290,581 | 1,803,523 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-17 Option Award | 2023-01-19 5:02 pm | N/A 2033-01-16 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 152,000 | $0 | 152,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:59 pm | N/A 2033-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:52 pm | N/A 2033-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 320,000 | $0 | 320,000 (Direct) | View |
| 2022-12-12 Other | 2022-12-14 4:54 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner | 600,854 | $0 | 6,609,388 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-17 5:49 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO CFO and Secretary | 1,375 | $0 | 312,997 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-17 5:41 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 1,187 | $0 | 2,284,400 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-17 5:33 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 3,562 | $0 | 1,823,324 (Direct) | View |
| 2022-09-21 Other | 2022-09-22 4:00 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 1,500,000 | $0 | 8,464,301 (Direct) | View |
| 2022-09-21 Other | 2022-09-22 4:00 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 1,500,000 | $0 | 8,904,527 (Indirect) | View |
| 2022-09-19 Other | 2022-09-21 4:58 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner | 600,854 | $0 | 7,210,242 (Direct) | View |
| 2022-09-12 Option Award | 2022-09-14 7:34 pm | N/A 2032-09-11 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 33,900 | $0 | 33,900 (Direct) | View |
| 2022-09-12 Ownership | 2022-09-14 7:32 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 0 | $0 | 0 (Direct) | View |